Get the Stockscreener App
3.03
7.34%
-0.24
After Hours:
3.04
0.01
+0.33%
Mereo Biopharma Group Plc ADR Stock (MREO) Forecast
The Mereo Biopharma Group Plc ADR (MREO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.3951, representing a -53.96% decrease from the current price of $3.03. The highest analyst price target is $2.7229, and the lowest is $0.0674.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MREO Price Target
Average 1.3784
(-54.51% Downside)
Is Mereo Biopharma Group Plc ADR (MREO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.22 | Neutral |
| STOCH(9,6) | 67.61 | Neutral |
| STOCHRSI(14) | 48.86 | Neutral |
| MACD(12,26) | 0.0239 | Buy |
| ADX(14) | 19.25 | Neutral |
| William %R | -45.07 | Neutral |
| CCI(14) | 55.87 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.084
Sell
|
3.0619
Sell
|
| MA20 |
2.8985
Buy
|
3.0172
Buy
|
| MA50 |
3.1166
Sell
|
3.0646
Sell
|
| MA100 |
3.1562
Sell
|
2.95
Buy
|
| MA200 |
2.3931
Buy
|
2.5294
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, MREO could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on MREO, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.22 indicates that MREO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 67.61 indicates that MREO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.86 indicates that MREO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 55.87 indicates that MREO is still overbought but not to an extreme extent.
Long-term MREO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mereo Biopharma Group Plc ADR financial reports and earnings history, Mereo Biopharma Group Plc ADR (MREO) stock could reach $1.0265 by 2030, $3.6904 by 2040 and $7.4745 by 2050. See the projected annual prices until 2050 of the Mereo Biopharma Group Plc ADR stock below:
- Mereo Biopharma Group Plc ADR (MREO) is expected to reach an average price of $0.6697 in 2035, with a high prediction of $0.8205 and a low estimate of $0.7897. This indicates an $-77.90% rise from the last recorded price of $3.03.
- Mereo Biopharma Group Plc ADR (MREO) stock is projected to chart a bullish course in 2040, with an average price target of $3.2493, representing an $7.24% surge from its current level. The forecast ranges from a conservative $3.5993 to a sky-high $3.6904.
- Our analysts predict Mereo Biopharma Group Plc ADR (MREO) to jump 82.95% by 2045, soaring from $5.5347 to an average price of $5.5432, potentially reaching $5.6089. While $5.5347 is the low estimate, the potential upside is significant.
- Mereo Biopharma Group Plc ADR (MREO) stock is expected to climb by 2050, reaching an average of $7.336, a $142.11% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.4745 and $7.466, respectively, highlighting the market's uncertainty.
Mereo Biopharma Group Plc ADR Stock (MREO) Year by Year Forecast
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2024
Our forecast for MREO stock price in 2024 now indicates an average price target of $2.1969 with a high forecast of $4.36 and a low forecast of $0.0339. The average prediction reflects an decrease of -27.49% from the last recorded price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.2726 | $0.0674 | $2.7229 | -91.00% |
| July, 2024 | $0.3688 | $0.0339 | $1.1523 | -87.83% |
| August, 2024 | $1.6828 | $0.0466 | $2.0507 | -44.46% |
| September, 2024 | $0.9948 | $0.8947 | $1.965 | -67.17% |
| October, 2024 | $1.1608 | $0.5544 | $1.5908 | -61.69% |
| November, 2024 | $0.7238 | $0.5738 | $1.4885 | -76.11% |
| December, 2024 | $0.0433 | $0.057 | $0.6302 | -98.57% |
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2025
Mereo Biopharma Group Plc ADR Stock (MREO) is expected to reach an average price of $1.1157 in 2025, with a high prediction of $2.187 and a low estimate of $0.0444. This indicates an -63.18% fall from the last recorded price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.6429 | $0.253 | $1.5858 | -78.78% |
| February, 2025 | $0.4748 | $0.0444 | $0.8321 | -84.33% |
| March, 2025 | $0.2415 | $0.4512 | $0.3555 | -92.03% |
| April, 2025 | $1.0601 | $0.468 | $1.0351 | -65.01% |
| May, 2025 | $0.7721 | $0.8121 | $1.0318 | -74.52% |
| June, 2025 | $0.7392 | $0.8889 | $0.7189 | -75.60% |
| July, 2025 | $1.317 | $0.2737 | $2.187 | -56.54% |
| August, 2025 | $0.9299 | $0.7599 | $1.6402 | -69.31% |
| September, 2025 | $0.7828 | $0.4796 | $1.393 | -74.16% |
| October, 2025 | $0.719 | $0.5661 | $1.3225 | -76.27% |
| November, 2025 | $0.6119 | $0.4323 | $1.0855 | -79.80% |
| December, 2025 | $0.3781 | $0.0684 | $0.6849 | -87.52% |
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2026
The predicted value for Mereo Biopharma Group Plc ADR (MREO) in 2026 is set at an average of $1.4107. Estimates vary from a peak of $2.7775 to a trough of $0.044, indicating an -53.44% surge from the present price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.456 | $0.2646 | $0.5813 | -84.95% |
| February, 2026 | $1.5735 | $0.044 | $2.284 | -48.07% |
| March, 2026 | $1.3669 | $1.2273 | $1.8104 | -54.89% |
| April, 2026 | $2.4631 | $0.6534 | $2.7631 | -18.71% |
| May, 2026 | $2.086 | $1.3995 | $2.7775 | -31.15% |
| June, 2026 | $2.1689 | $1.2425 | $2.4592 | -28.42% |
| July, 2026 | $1.2051 | $0.8751 | $2.2322 | -60.23% |
| August, 2026 | $1.298 | $1.0383 | $1.8648 | -57.16% |
| September, 2026 | $1.1342 | $0.8942 | $1.7013 | -62.57% |
| October, 2026 | $0.8472 | $0.5439 | $1.1507 | -72.04% |
| November, 2026 | $0.9501 | $0.2586 | $1.0904 | -68.64% |
| December, 2026 | $0.6163 | $0.4663 | $1.0933 | -79.66% |
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mereo Biopharma Group Plc ADR (MREO) is $0.5899, with a high forecast of $1.1476 and a low forecast of $0.0322. This indicates an -80.53% decrease from the last price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3392 | $0.2692 | $0.7728 | -88.81% |
| February, 2027 | $0.2121 | $0.0322 | $0.6989 | -93.00% |
| March, 2027 | $0.0717 | $0.0646 | $0.2654 | -97.63% |
| April, 2027 | $0.3388 | $0.2085 | $0.3188 | -88.82% |
| May, 2027 | $0.5258 | $0.5758 | $0.4923 | -82.65% |
| June, 2027 | $0.5897 | $0.5897 | $0.5029 | -80.54% |
| July, 2027 | $0.6067 | $0.5332 | $0.3732 | -79.98% |
| August, 2027 | $0.9738 | $0.6635 | $0.7538 | -67.86% |
| September, 2027 | $1.1766 | $1.1206 | $1.1476 | -61.17% |
| October, 2027 | $0.3847 | $1.1246 | $1.1444 | -87.30% |
| November, 2027 | $0.3018 | $0.4268 | $0.275 | -90.04% |
| December, 2027 | $0.3056 | $0.1852 | $0.3588 | -89.91% |
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2028
In 2028, Mereo Biopharma Group Plc ADR (MREO) is projected to reach an average price of $0.5525, with a high projection of $0.8843 and a low estimate of $0.2207. This indicates an -81.77% fall from the last price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5727 | $0.4759 | $0.4827 | -81.10% |
| February, 2028 | $0.7686 | $0.6262 | $0.7197 | -74.63% |
| March, 2028 | $0.6137 | $0.6636 | $0.6036 | -79.75% |
| April, 2028 | $0.8334 | $0.8293 | $0.7806 | -72.49% |
| May, 2028 | $1.0838 | $0.8208 | $0.8843 | -64.23% |
| June, 2028 | $0.6015 | $0.7447 | $0.8078 | -80.15% |
| July, 2028 | $0.5745 | $0.6318 | $0.545 | -81.04% |
| August, 2028 | $0.7624 | $0.5753 | $0.599 | -74.84% |
| September, 2028 | $0.6412 | $0.7959 | $0.6927 | -78.84% |
| October, 2028 | $0.3165 | $0.3765 | $0.4762 | -89.55% |
| November, 2028 | $0.4404 | $0.3901 | $0.4236 | -85.47% |
| December, 2028 | $0.1674 | $0.2207 | $0.1374 | -94.47% |
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2029
The 2029 price forecast for Mereo Biopharma Group Plc ADR Stock (MREO) is $1.5115 on average, with a high prediction of $2.9922 and a low estimate of $0.0308. This represents an -50.12% decrease from the previous price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1413 | $0.241 | $0.1745 | -95.34% |
| February, 2029 | $0.1417 | $0.2383 | $0.1717 | -95.32% |
| March, 2029 | $0.1146 | $0.0986 | $0.3149 | -96.22% |
| April, 2029 | $0.1425 | $0.1222 | $0.2378 | -95.30% |
| May, 2029 | $0.6637 | $0.0308 | $0.9737 | -78.10% |
| June, 2029 | $0.8166 | $0.4534 | $0.9502 | -73.05% |
| July, 2029 | $0.9196 | $0.5499 | $1.0596 | -69.65% |
| August, 2029 | $2.4157 | $0.8428 | $2.8025 | -20.27% |
| September, 2029 | $2.3187 | $2.0687 | $2.9922 | -23.48% |
| October, 2029 | $1.6348 | $1.5138 | $2.7151 | -46.04% |
| November, 2029 | $1.3078 | $1.1928 | $2.1413 | -56.84% |
| December, 2029 | $0.88 | $0.13 | $1.8975 | -70.96% |
Mereo Biopharma Group Plc ADR Stock (MREO) Price Forecast for 2030
Mereo Biopharma Group Plc ADR Stock (MREO) is expected to reach an average price of $1.6936 in 2030, with a high forecast of $3.1402 and a low forecast of $0.2471. This signifies an -44.11% decrease from the last price of $3.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1177 | $0.2471 | $1.0265 | -63.11% |
| February, 2030 | $2.2618 | $1.6582 | $1.7918 | -25.35% |
| March, 2030 | $1.5559 | $1.8459 | $1.6189 | -48.65% |
| April, 2030 | $0.7601 | $0.8365 | $1.5495 | -74.92% |
| May, 2030 | $1.4177 | $1.2171 | $1.3977 | -53.21% |
| June, 2030 | $1.0718 | $1.1418 | $1.0812 | -64.63% |
| July, 2030 | $2.2395 | $1.4754 | $1.7811 | -26.09% |
| August, 2030 | $3.0636 | $2.2466 | $2.7836 | +1.11% |
| September, 2030 | $2.1932 | $1.7742 | $1.4178 | -27.62% |
| October, 2030 | $2.5754 | $2.185 | $2.3819 | -15.00% |
| November, 2030 | $3.1496 | $2.5725 | $2.2496 | +3.95% |
| December, 2030 | $3.1937 | $3.2537 | $3.1402 | +5.40% |
0.84%
0.10%
Cap:
|
Volume (24h):